|
MAP1LC3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.642000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.455000E-01 |
| Normal-vs-Stage2 |
8.993800E-01 |
| Normal-vs-Stage3 |
1.150580E-01 |
| Normal-vs-Stage4 |
6.640600E-01 |
| Stage1-vs-Stage2 |
8.474200E-01 |
| Stage1-vs-Stage3 |
3.982400E-02 |
| Stage1-vs-Stage4 |
6.227600E-01 |
| Stage2-vs-Stage3 |
1.972180E-01 |
| Stage2-vs-Stage4 |
6.407600E-01 |
| Stage3-vs-Stage4 |
3.637600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.090400E-01 |
| Normal-vs-AfricanAmerican |
8.933400E-01 |
| Normal-vs-Asian |
8.665000E-01 |
| Caucasian-vs-AfricanAmerican |
9.120400E-01 |
| Caucasian-vs-Asian |
8.901600E-01 |
| AfricanAmerican-vs-Asian |
9.958200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.296400E-01 |
| Normal-vs-Female |
6.543600E-01 |
| Male-vs-Female |
9.220400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.520200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.306600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.943230E-01 |
| Normal-vs-Age(81-100Yrs) |
7.976400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.925900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.284100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.216000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.552600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.404200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.051000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.169800E-01 |
| Classical-VS-Follicular |
3.338500E-02 |
| Classical-VS-Other |
2.080000E-01 |
| Classical-VS-Normal |
7.170200E-01 |
| Tall-VS-Follicular |
6.958400E-01 |
| Tall-VS-Other |
4.956200E-01 |
| Tall-VS-Normal |
3.765200E-01 |
| Follicular-VS-Other |
7.348400E-01 |
| Follicular-VS-Normal |
1.684840E-01 |
| Other-VS-Normal |
2.520600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.862200E-01 |
| Normal-vs-N1 |
4.552200E-01 |
| N0-vs-N1 |
8.837800E-01 |
|
|
